Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...
A German court found Wednesday that American pharmaceutical giant Pfizer and German firm BioNTech violated a patent to make ...
Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s ...
Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...
As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech ...
CNET on MSN17h
How the 3 New COVID Vaccines Change the Way You PayNow that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and more.
It has been five years since the World Health Organisation (WHO) declared COVID-19 a pandemic in March 2020 a decision that ...
6h
Axios on MSNStates push fight against mRNA vaccinesThe mRNA vaccines that helped to end the COVID pandemic — and stoked a considerable amount of vaccine skepticism and ...
Dr. Jay Bhattacharya told Sen. Josh Hawley that he supports developing alternatives for vaccines and therapeutics that use aborted cell lines.
23h
Nordot on MSNModerna wins patent lawsuit against BioNTech/Pfizer in German courtA German court ruled on Wednesday that BioNTech and Pfizer violated a Covid-19 patent held by rival Moderna. US-based Moderna ...
Cornell researchers have developed a stable, multi-target vaccine offering long-lasting protection against COVID-19 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results